These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24321238)

  • 1. Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.
    Limantoro I; De Vos CB; Delhaas T; Marcos E; Blaauw Y; Weijs B; Tieleman RG; Pisters R; Schotten U; Van Gelder IC; Crijns HJ
    Heart Rhythm; 2014 Mar; 11(3):478-84. PubMed ID: 24321238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.
    De Vos CB; Limantoro I; Pisters R; Delhaas T; Schotten U; Cheriex EC; Tieleman RG; Crijns HJ
    Heart Rhythm; 2014 Sep; 11(9):1514-21. PubMed ID: 24768608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of echocardiographic tissue velocity imaging abnormalities of the left atrial wall during atrial fibrillation.
    Limantoro I; de Vos CB; Delhaas T; Weijs B; Blaauw Y; Schotten U; Kietselaer B; Pisters R; Crijns HJ
    Europace; 2014 Nov; 16(11):1546-53. PubMed ID: 24668517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillatory wall motion and degree of atrial remodeling in patients with atrial fibrillation: a tissue velocity imaging study.
    De Vos CB; Pison L; Pisters R; Schotten U; Cheriex EC; Prins MH; Delhaas T; Crijns HJ; Tieleman RG
    J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1374-81. PubMed ID: 19817923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue velocity imaging-based atrial fibrillatory cycle length and wall motion for predicting atrial structural remodeling in patients undergoing catheter ablation.
    Sonoda K; Okumura Y; Watanabe I; Nagashima K; Kofune M; Mano H; Kogawa R; Sasaki N; Ohkubo K; Nakai T; Hirayama A
    Circ J; 2014; 78(7):1619-27. PubMed ID: 24848777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
    Ciolli A; De Sisti A; Montenero AS; Sanna T; Lo Sardo G; Palamara A
    Cardiologia; 1998 Oct; 43(10):1077-82. PubMed ID: 9922572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthoracic tissue Doppler imaging of the atria: a novel method to determine the atrial fibrillation cycle length.
    Duytschaever M; Heyse A; de Sutter J; Crijns H; Gillebert T; Tavernier R; Tieleman R
    J Cardiovasc Electrophysiol; 2006 Nov; 17(11):1202-9. PubMed ID: 16968525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
    Boriani G; Biffi M; Capucci A; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Magnani B
    J Am Coll Cardiol; 1999 Feb; 33(2):333-41. PubMed ID: 9973012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation.
    Climent VE; Marin F; Mainar L; Gomez-Aldaravi R; Martinez JG; Chorro FJ; Roman P; Sogorb F
    Pacing Clin Electrophysiol; 2004 Mar; 27(3):368-72. PubMed ID: 15009866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.
    Bollmann A; Binias KH; Toepffer I; Molling J; Geller C; Klein HU
    Am J Cardiol; 2002 Nov; 90(9):1011-4. PubMed ID: 12398975
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
    Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Doppler flow of atrial fibrillatory contraction and recurrence of atrial fibrillation after electrical cardioversion.
    Kim H; Lee JP; Yoon HJ; Park HS; Cho YK; Nam CW; Hur SH; Kim YN; Kim KB
    J Am Soc Echocardiogr; 2014 Oct; 27(10):1107-12. PubMed ID: 24984584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive determination of atrial fibrillation cycle length by atrial colour tissue Doppler imaging in horses.
    Decloedt A; de Clercq D; van der Vekens N; Verheyen T; van Loon G
    Equine Vet J; 2014 Mar; 46(2):174-9. PubMed ID: 23738919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Mast F; Allessie MA
    Circulation; 2000 Jul; 102(2):260-7. PubMed ID: 10889140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring.
    Weijs B; Limantoro I; Delhaas T; de Vos CB; Blaauw Y; Houben RPM; Verheule S; Pisters R; Crijns HJGM
    Clin Cardiol; 2018 Mar; 41(3):366-371. PubMed ID: 29569353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.